Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2005-04-12
2005-04-12
Henley, III, Raymond (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C514S734000, C514S736000
Reexamination Certificate
active
06878751
ABSTRACT:
A method is provided for treating inflammatory respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The method involves administration, preferably oral or pulmonary administration, of an active agent selected from the group consisting of resveratrol, pharmacologically acceptable salts, esters, amides, prodrugs and analogs thereof, and combinations of any of the foregoing. Pharmaceutical formulations for use in conjunction with the aforementioned method are provided as well.
REFERENCES:
patent: 4176180 (1979-11-01), Barbier
patent: 5411986 (1995-05-01), Cho et al.
patent: 5747536 (1998-05-01), Cavazza
patent: 6022901 (2000-02-01), Goodman
patent: 6329422 (2001-12-01), Fischer et al.
patent: 6414037 (2002-07-01), Pezzuto et al.
patent: 6551616 (2003-04-01), Notario et al.
patent: 1138323 (2001-10-01), None
patent: 9404148 (1994-03-01), None
patent: WO 0013685 (2000-03-01), None
patent: WO 0038620 (2000-07-01), None
patent: WO 0108671 (2001-02-01), None
Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Ninth Edition, Chapter 28, pp. 666-669 (1996).*
American Drug Index, 42ndEdition, pp. 674, 746 (1998).*
Ashby et al. (1999), “Partial and Weak Oestrogenicity of the Red Win Constituent Resveratrol: Consideration of its Superagonist Activity in MCF-7 Cells and its Suggested Cardiovascular Protective Effects,”J. Appl. Toxicol. 19:39-45.
Barner et al. (1998), “Transcription Factors and Asthma,”Eur. Respir. J. 12(1):221-234.
Bertelli et al. (1995) “Antiplatelet Activity of Synthetic and Natural Resveratrol in Red Wine,”Inst. J. Tiss. Reac. XVII(1):1-3.
Bertram (1979), “Reduction in the Formation of Cardinogen-Induced Transformed Foci by Penicillin G Sodium in the C3H/10T1/2CL8 Cell Line,”Cancer Lett. 7:289-298.
Blackwell et al. (1997), “The Role of Nuclear Factor-κB in Cytokine Gene Regulation,”Am. J. Respir. Cell Mol. Biol. 17:3-9.
Bowers et al. (2000), “Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors Alpha and Beta,”Endocrinology 141(10):3657-3667.
Cazzola et al. (2000), “Potential Role of Macrolides in the Treatment of Asthma,”Monaldi Arch. Chest Dis. 55(3):231-236.
Damianaki et al. (2000), “Potent Inhibitory Action of Red Wine Polyphenols on Human Breast Cancer Cells,”Journal of Cellular Biochemistry 78:429-441.
Dweik et al. (1997), “Nitric Oxide Synthase in the Human Airway Epithelium,”Acta Pharmacologica Sinica 18(6):550-552.
ElAttar et al. (1999), “Modulating Effect of Resveratrol and Quercetin on Oral Cancer Cell Growth and Proliferation,”Anti-Cancer Drugs 10:187-193.
Frankel et al. (1993) “Inhibition of Human LDL Oxidation by Resveratrol,”The Lancet 341:1103-1104.
Fröde-Saleh et al. (2000), “Synergistic Antiinflammatory Effect of NF-78 B Inhibitors and Steroidal or Non Steroidal Antiinflammatory Drugs in the Pleural Inflammation Induced by Carrageenan in Mice,”Inflammation Research 49(7):330-337.
Gerhäuser et al. (1995), “Retinoids Mediate Potent Cancer Chemopreventive Activity Through Transcriptional Regulation of Ornithine Decarboxylase,”Nature Med. 1(3)260-266.
Goldberg et al. (1994) “Direct Injection Gas Chromatographic Mass Spectrometric Assay for trans-Resveratrol,”Anal. Chem. 66:3959-3963.
Goldberg et al. (1995), “Direct Gas Chromatographic—Mass Spectrometric Method to Assay cis-Resveratrol in Wines: Preliminary Survey of Its Concentration in Commercial Wines,”J. Agric. Food Chem. 43:1245-1250.
Goldberg et al. (1995) “A Global Survey of Trans-Resveratrol Concentrations in Commercial Wines,”Am. J. Enol. Vitic. 46(2):159-165.
Goldberg et al. (1996) “Method to Assay the Concentrations of Phenolic Constituents of Biological Interest in Wines,”Anal. Chem. 68:1688-1694.
Goodwin (1984), “Immunologic Effects of Nonsteroidal Anti-Inflammatory Drugs,”Am. J. Med. 77:7-15.
Guo et al. (1997), “Interferon γ and Interleukin 4 Stimulate Prolonged Expression of Inducible Nitric Oxide Synthase in Human Airway Epithelium Through Synthesis of Soluble Mediators,”J. Clin. Invest. 100(4):829-838.
Guo et al. (1998), “Characterization of Inducible Nitric Oxide Synthase Expression in Human Airway Epithelium,”Environ. Health Perspect. 106(Suppl. 5):1119-1124.
Guo et al. (2000), “Molecular Mechanisms of Increased Nitric Oxide (NO) in Astham: Evidence for Transcriptional and Post-Translational Regulation of NO Synthesis,”J. Immunol. 164(11):5970-5980.
Jang et al. (1997) “Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes,”Science 275:218-220.
Jayatilake et al. (1993), “Kinase Inhibitors From Polygonum Cuspidatum,”J. Nat. Proc. 56(10):1805-1810.
Jeandet et al. (1991) “The Production of Reseveratrol 3,5,4′-Trihydroxystilbene) by Grape Berries in Different Developmental Stages,”Am. J. Enol. Vitic. 42(1):41-46.
Kawanda et al. (1998), “Effect of Antioxidants, Resveratrol, Quercetin, and N-Acetylcysteine, on the Functions of Cultured Rat Hepatic Stellate Cells and Kupffer Cells,”Hepatology 27(5):1265-1274.
Kulmacz et al. (1987), “Cycl-Oxygenase: Measurement, Purification and Properties,”Prostaglandins and Related Substances,IRL Press, Oxford, pp. 209-277.
Landolph (1985), “Chemical Transformation in C3H 10T1/2C18 Mouse Embryo Fibroblasts: Hstorical Background, Assessment of the Transformation Assay, and Evolution and Optimization of the Transformation Assay Protocol,”Transformation Assay of Established Cell Lines: Mechanisms and Application,T. Kakunaga et al., eds., Oxford Univ. Press, Toronto, pp. 185-199.
Lee et al. (1994), “Protection of Cell Injury Against Oxidative Stress By Resveratrol,”Society for Neuroscience Abstracts 20(2):1648.
Manna et al. (2000), “Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation,”J. Immunol. 164(12):6509-6519.
Mannila et al. (1993), “Anti-Leukaemic Compounds Derived From Stilbenes inPicea AbiesBark,”Phytochemistry 33(4):813-816.
Martinez et al. (2000), “Effect of Resveratrol, a Natural Polyphenolic Compound, on Reactive Oxygen Species and Prostaglandin Production,”Biochem. Pharmacol. 59:865-870.
Misko et al. (1993), “A Fluorometric Assay for the Measurement of Nitrite in Biological Samples,”Anal. Biochem. 214:11-16.
Mondal et al. (1976), “Two-Stage Chemical Oncogenesis In Cultures of C3H/10T1/2Cells,”Cancer Res. 36:2254-2260.
Moon et al. (1990), “Retinoid Inhibition of Experimental Carcinogenesis,”Chemistry and Biology of Synthetic Retinoids,M.I. Dawson et al., eds., CRC Press, Boca Raton, FL, 501-518.
Moren-Mañas. (1985) “Dehydroacetic Acid Chemistry, A New Synthesis of Resveratrol, a Phytoalexine ofVitis Vinifera,” Anal. Quim 81:157-161.
Newton et al. (1996), “Superinduction of NF-κB by Actinomycin D and Cycloheximide in Epithelial Cells,”Bichem. Biophys. Res. Commun. 218:518-523.
Pace-Asciak et al. (1995), “The Red Wine Phenolics Trans-Resveratrol and Quercetin Block Human Platelet Aggregation and Eicosanoid Synthesis: Implications for Protection Against Coronary Heart Disease,”Clinica Chimica Acta 235:207-219.
Pang et al. (2000), “Synergistic Inhibition by β2-Agonists and Corticosteroids on Tumor Necrosis Factor-α-Induced Interleukin-8 Release from Cultured Human Airway Smooth-Muscle Cells,”Am. J. Respir. Cell Mol. Biol. 23(1):79-85.
Plescia et al. (1975), “Subversion of Immune System By Tumor Cells and Role of Prostaglandins,”Proc. Natl. Acad. Sci., USA 72(5):1848-1851.
Prochaska et al. (1988), “Direct Measurement
Barnes Peter John
Donnelly Louise Elizabeth
Canaan Karen
Delacroix-Muirheid Cybille
Henley III Raymond
Imperial College Innovations Limited
Imperial College of Science Technology and Medicine
LandOfFree
Administration of resveratrol to treat inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of resveratrol to treat inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of resveratrol to treat inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3395898